APA (7th ed.) Citation

Giatrakis, C., Kartikasari, A. E. R., Angelovich, T. A., Flanagan, K. L., Churchill, M. J., Scott, C. L., . . . Plebanski, M. (2025). HCMV as an Oncomodulatory Virus in Ovarian Cancer: Implications of Viral Strain Heterogeneity, Immunomodulation, and Inflammation on the Tumour Microenvironment and Ovarian Cancer Progression. Biomolecules (2218-273X), 15(12), 1685. https://doi.org/10.3390/biom15121685

Chicago Style (17th ed.) Citation

Giatrakis, Chrissie, Apriliana E. R. Kartikasari, Thomas A. Angelovich, Katie L. Flanagan, Melissa J. Churchill, Clare L. Scott, Srinivasa Reddy Telukutla, and Magdalena Plebanski. "HCMV as an Oncomodulatory Virus in Ovarian Cancer: Implications of Viral Strain Heterogeneity, Immunomodulation, and Inflammation on the Tumour Microenvironment and Ovarian Cancer Progression." Biomolecules (2218-273X) 15, no. 12 (2025): 1685. https://doi.org/10.3390/biom15121685.

MLA (9th ed.) Citation

Giatrakis, Chrissie, et al. "HCMV as an Oncomodulatory Virus in Ovarian Cancer: Implications of Viral Strain Heterogeneity, Immunomodulation, and Inflammation on the Tumour Microenvironment and Ovarian Cancer Progression." Biomolecules (2218-273X), vol. 15, no. 12, 2025, p. 1685, https://doi.org/10.3390/biom15121685.